ARCHIVES

ZBB Considered Useless By NCI Staff (Privately)’ New Approach Groups Program Into Four Categories

This article is from The Cancer Letter archive.

Vol. 04 No. 40 | October 6, 1978

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Sets NCI rescission At $14 Million Baltimore Program Conversation To Cancer Center Will Be asked

May 15, 1981

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Special Report: Politicla Pressure, System Loopholes, Enabled Burzynski To Avoid Usuals

September 25, 1998

The Meeting At the Beverly Hills Suite: Salick, Zeneca Par Way Acrimoniously

May 2, 1997

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Adverse Events Of Chemo More Common Than Expected

August 25, 2006